High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure - Top-Institutions - MDSpire

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure

  • By

  • Gargi Banerjee

  • Tze How Mok

  • Harpreet Hyare

  • Oliver Cousins

  • Zane Jaunmuktane

  • Simon Mead

  • John Collinge

  • May 1, 2026

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    UK National Prion Clinic
    UK National Prion Clinic

    London, England

    Key Differentiators

    • Neurology

  • #2

    University College London Queen Square Institute of Neurology
    University College London Queen Square Institute of Neurology

    London, England

    Key Differentiators

    • Neurology

  • #3

    University of Edinburgh
    University of Edinburgh

    Edinburgh, Scotland

    Key Differentiators

    • Neurology

  • #4

    UCSD Shiley-Marcos Alzheimer’s Disease Research Center
    UCSD Shiley-Marcos Alzheimer’s Disease Research Center

    La Jolla, California

    Key Differentiators

    • Alzheimer's Disease Research

  • #5

    University of California, San Diego
    University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Neurology

Original Source(s)

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure

  • by Gargi Banerjee, Tze How Mok, Harpreet Hyare, Oliver Cousins, Zane Jaunmuktane, Simon Mead, John Collinge

  • May 1, 2026

Related Content

Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration

Association between circulating biomarkers of one-carbon metabolism and glymphatic system function in cognitive decline of Alzheimer’s disease

Anti-Aβ3–10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-κB pathway